Reversal of axonal growth defects in an extraocular fibrosis model by engineering the kinesin–microtubule interface

Citations Over TimeTop 14% of 2016 papers

Abstract

Mutations in human β3-tubulin (TUBB3) cause an ocular motility disorder termed congenital fibrosis of the extraocular muscles type 3 (CFEOM3). In CFEOM3, the oculomotor nervous system develops abnormally due to impaired axon guidance and maintenance; however, the underlying mechanism linking TUBB3 mutations to axonal growth defects remains unclear. Here, we investigate microtubule (MT)-based motility in vitro using MTs formed with recombinant TUBB3. We find that the disease-associated TUBB3 mutations R262H and R262A impair the motility and ATPase activity of the kinesin motor. Engineering a mutation in the L12 loop of kinesin surprisingly restores a normal level of motility and ATPase activity on MTs carrying the R262A mutation. Moreover, in a CFEOM3 mouse model expressing the same mutation, overexpressing the suppressor mutant kinesin restores axonal growth in vivo. Collectively, these findings establish the critical role of the TUBB3-R262 residue for mediating kinesin interaction, which in turn is required for normal axonal growth and brain development.

Related Papers

• → Direct observation of single kinesin molecules moving along microtubules(1996)717 cited
• → Single Molecule Imaging Reveals Differences in Microtubule Track Selection Between Kinesin Motors(2009)314 cited
• → Diffusive Movement of Processive Kinesin‐1 on Microtubules(2009)50 cited
• → The axonal transport motor kinesin‐2 navigates microtubule obstacles via protofilament switching(2017)38 cited
• → In Vitro Analysis of the Effect of Microtubule Acetylation on Kinesin Motility(2010)